Life Sciences Conference Presentation

Mid-Atlantic BioTherapeutics to Present AI-Enabled Therapeutics at Moody Capital Solutions Conference

Mid-Atlantic BioTherapeutics, Inc. is set to present at the Moody Capital Solutions 2026 Disruptive Growth & Life Sciences Conference in New York City, taking place on September 9-10, 2026. David Horn, CEO of Mid-AtlanticBioTherapeutic, will deliver an investor presentation and participate in scheduled 1-on-1 meetings with investors. The conference, which brings together public and private growth companies, pioneering innovators, investors, C-suite executives and industry professionals across biotechnology, medical devices, pharmaceuticals, healthcare technology and other growth industries, will also feature company presentations, one-onetime investor meetings, capital markets and financing panels, and networking opportunities with institutional investors and family offices. The company's focus is on the clinical development and commercialization of novel therapeutic approaches using AI-enabled technologies.